Jing Rong Cui
Fondatore presso Blossomhill Therapeutics, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Yi Shan Li | M | 59 |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 11 anni |
| Carl Gordon | M | 59 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 4 anni |
| Scott Lipman | M | - | 4 anni | |
| Bihua Chen | F | 55 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
| George Lee | M | 73 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
| Gavin Hirst | M | - | 4 anni | |
| Naresh K. Nayyar | M | - | 6 anni | |
| Miriam Cruz | F | - | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Athena Countouriotis | M | 52 | - | |
| Brian Baker | M | 57 | 4 anni | |
| Garry Nicholson | M | 69 | 2 anni | |
| Clarence Machado | M | 60 | 3 anni | |
| Jacob Chacko | M | 45 | 3 anni | |
| Sheila Gujrathi | M | 53 | 4 anni | |
| Carol Gallagher | M | 59 | 3 anni | |
| Simeon George | M | 47 | 5 anni | |
| Hong Bo Lu | M | 53 | 2 anni | |
| Annette C. North | F | 58 | 3 anni | |
| Robert J. Adelman | M | 61 | - | |
| Lewis J. Shuster | M | 68 | - | |
| Dana Hu-Lowe | M | - | 2 anni | |
| Brett Zbar | M | 51 | 1 anni | |
| Mohammad Hirmand | M | 54 | 3 anni | |
| Yuelie Lu | M | 66 | 1 anni | |
| Kenneth Fong | M | - | - | |
| Siegfried Reich | M | 64 | 2 anni | |
| Homa Yeganegi | F | - | - | |
| Jakob Loven | M | 46 | 1 anni | |
| Yi Larson | F | 44 | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 29 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jing Rong Cui
- Contatti personali
